Home/Filings/4/0001104659-20-139064
4//SEC Filing

He Wei-Wu 4

Accession 0001104659-20-139064

CIK 0000895051other

Filed

Dec 22, 7:00 PM ET

Accepted

Dec 23, 4:02 PM ET

Size

7.2 KB

Accession

0001104659-20-139064

Insider Transaction Report

Form 4
Period: 2020-12-22
He Wei-Wu
Director
Transactions
  • Gift

    Common Stock

    2020-12-22380,0004,683,994 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    441,072
  • Common Stock

    (indirect: See Footnote)
    7,532,347
Footnotes (3)
  • [F1]Dr. He gifted 380,000 shares to a foundation.
  • [F2]The shares are held indirectly in the name of ETP Global Fund LP, a limited partnership of which the Reporting Person is the managing member of the general partner. The Reporting Person disclaims beneficial ownership over any shares held indirectly, except to the extent of his pecuniary interest therein and his filing is not an admission that the Reporting Person is the beneficial owner of these shares for purposes of Section 16 or any other purposes.
  • [F3]The shares are held indirectly in the name of Emerging Technology Partners, LLC, an LLC entity of which the Reporting Person is the managing member. The Reporting Person disclaims beneficial ownership over any shares held indirectly, except to the extent of his pecuniary interest thein and his filing is not an admission that the Reporting Person is the beneficial owner of these shares for the purposes of Section 16 or any other purposes.

Issuer

CASI Pharmaceuticals, Inc.

CIK 0000895051

Entity typeother

Related Parties

1
  • filerCIK 0001542073

Filing Metadata

Form type
4
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 4:02 PM ET
Size
7.2 KB